Annual Meeting

Out with the old, in with the nucleus

Learn about the Discover BMB 2024 symposium on signaling mechanisms in the nucleus
Glen Liszczak Aaron Johnson
By Glen Liszczak and Aaron Johnson
Sept. 21, 2023

Are you tired of binging reruns on Netflix?  Maybe you need a break from reality TV but you’re not sure where to turn for high-quality entertainment?  Look no further — the nucleus has it all.  There’s mystery, murder, machines of extraordinary complexity and visually stunning landscapes. 

Stories in nuclear signaling are unraveling at an unprecedented pace thanks to technological and conceptual advances in chemistry, biochemistry and cell biology. Our speakers will address long-standing questions about organism development, cellular identity and the genetic basis for disease. 

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.

You will hear about how cutting-edge interdisciplinary approaches are being used to uncover new regulatory mechanisms underlying transcription, genome structure, and other phenomena in the nucleus. We will also discuss how rapid progress in the field is inspiring new therapeutic approaches for diseases related to dysfunctional nuclear processes.

You don’t want to miss this — even the cytosol junkies will be on the edge of their seats.

Keywords:  Enzyme mechanism, genetics and disease, chemical probes, transcription regulation, chromatin modifications, genome structure.

Who should attend: You. Our speakers span a wide breadth of biological phenomena, scientific disciplines and technologies. We have something for everyone. Current projections: standing room only.

Your session’s theme song“Journey to the Island” by John Williams

This song is about the most important genetics experiment ever performed.

This session is powered by “hot, nasty, bad-*ss speed.” — Eleanor Roosevelt, Talladega Nights

Signaling mechanisms in the nucleus

Chemical strategies to study nuclear processes

Chair: Aaron Johnson

Anna MappUniversity of Michigan

Glen LiszczakUniversity of Texas Southwestern Medical Center

Oliver BellUniversity of Southern California Kerk School of Medicine

Minkui LuoMemorial Sloan Kettering Cancer Center

Chromatin organization, replication and repair

Chair: Katharine Diehl

Aaron StreetsUniversity of California, Berkeley

Aaron JohnsonUniversity of Colorado Anschutz Medical Campus

Carl WuJohns Hopkins University

Serena Sanulli, Stanford University

Chromatin modifications in the nucleus

Chair: Glen Liszczak

Alex RuthenbergUniversity of Chicago

Katharine DiehlUniversity of Utah

Tim StasevichColorado State University

Phil ColeHarvard University

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Glen Liszczak
Glen Liszczak

Glen Liszczak is an assistant professor in the biochemistry department at the University of Texas Southwestern Medical Center.

Aaron Johnson
Aaron Johnson

Aaron Johnson is an associate professor in the biochemistry and molecular genetics department at the University of Colorado School of Medicine.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Catching tau in the act
Journal News

Catching tau in the act

April 2, 2026

Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.

How copper delivery fuels bacterial respiration
Journal News

How copper delivery fuels bacterial respiration

April 1, 2026

Researchers identify the roles of several proteins in copper homeostasis in the aerobic bacterium Caulobacter vibrioides.

Revealing the glycoproteome of a cancer subtype
Journal News

Revealing the glycoproteome of a cancer subtype

March 31, 2026

Researchers mapped the glycoproteome of extrahepatic cholangiocarcinoma and compared it to intrahepatic tumors. Differences in sugar modifications and immune cell content suggest new biomarkers and guide development of targeted immunotherapies.

Uncovering the mechanisms of a glycosylation disorder
Journal News

Uncovering the mechanisms of a glycosylation disorder

March 27, 2026

Mutations in OGT, an enzyme that adds sugars to proteins, cause a rare neurological disorder. Using proteomics, researchers reveal how OGT interactions with TET proteins may trigger epigenetic changes and early neural defects.

Heat shock proteins as a promising breast cancer therapeutic
Journal News

Heat shock proteins as a promising breast cancer therapeutic

March 25, 2026

Researchers unveiled isoform-specific targets on heat shock protein 90 which may be beneficial in therapeutic development.

Optimized proteomic analysis of preserved biological tissue samples
Journal News

Optimized proteomic analysis of preserved biological tissue samples

March 25, 2026

Researchers have developed an optimized workflow for analyzing formalin-fixed paraffin-embedded tissue. This workflow provides an enhanced collection of unique proteins and phosphorylation sites for more detailed analysis of biological samples.